PSA, PSA density, PSA density of transition zone, free/total PSA ratio, and PSA velocity for early detection of prostate cancer in men with serum PSA 2.5 to 4.0 ng/mL

Urology

Volumn 54, Issue 3, 1999, Pages 517-522

  Djavan, Bob ^a   Zlotta, Alexandre ^b   Kratzik, Christian ^b   Remzi, Mesut ^b   Seitz, Christian ^b   Schulman, Claude C ^b   Marberger, Michael ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC VALUE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CARCINOMA; PROTEIN BLOOD LEVEL;

ADULT; AGED; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY;

EID: 0032838044     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(99)00153-3     Document Type: Article

References (16)

1. Catalona WJ, Smith DS, Wolfert RL, et al: Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. JAMA 274: 1214-1220, 1995.
2. Partin AW, and Carter HB: The use of prostate-specific antigen and free/total prostate-specific antigen in the diagnosis of localized prostate cancer. Urol Clin North Am 23: 531-540, 1996.
3. Vashi AR, Wojno KJ, Henricks W, et al: Determination of the "reflex range" and appropriate cutpoints for percent free prostate-specific antigen in 413 men referred for prostatic evaluation using the AxSYM system. Urology 49: 19-26, 1997.
4. Zlotta AR, Djavan B, Marberger M, et al: Prostate specific antigen density of the transition zone: a new effective parameter for prostate cancer prediction. J Urol 157: 1315-1321, 1997.
5. Djavan B, Zlotta AR, Byttebier G, et al: Prostate specific antigen density of the transition zone for early detection of prostate cancer. J Urol 160: 411-419, 1998.
6. Catalona WJ, Smith DS, and Ornstein DK: Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4 ng/mL and benign prostate examinations. JAMA 277: 1452-1455, 1997.
7. Partin AW, Criley SR, Subong EN, et al: Standard versus age-specific prostate specific antigen reference ranges among men with clinically localized prostate cancer: a pathological analysis. J Urol 155: 1336-1339, 1996.
8. Smith DS, Catalona WJ, and Herschman JD: Longitudinal screening for prostate cancer with prostate-specific antigen. JAMA 276: 1309-1315, 1996.
9. Gann PH, Hennekens CH, and Stampfer MJ: A prospective evaluation of plasma prostate-specific antigen for detection of prostate cancer. JAMA 273: 289-294, 1995.
10. Stenman UH, Hakama M, Knekt P, et al: Serum concentrations of prostate specific antigen and its complex with alpha-1-antichymotrypsin before diagnosis of prostate cancer. Lancet 344: 1594-1598, 1994.
11. Vashi AR, and Oesterling JE: Percent free prostate-specific antigen: entering a new era in the detection of prostate cancer. Mayo Clin Proc 72: 337-344, 1997.
12. Espana F, Martinez M, Montserrat R, et al: Reference ranges for the concentrations of total and complexed plasma prostate-specific antigen and their ratio in patients with benign prostate hyperplasia. Eur Urol 32: 268-272, 1997.
13. Stephan C, Lein M, Jung K, et al: The influence of prostate volume on the ratio of f/t prostate specific antigen in serum of patients with prostate carcinoma and benign prostate hyperplasia. Cancer 79: 104-109, 1997.
14. Zlotta AR, Djavan B, Roumeguère T, et al: Transition zone volume on transrectal ultrasonography is more accurate and reproducible than the total prostate volume (abstract). Br J Urol 80(suppl 2): A926, 1997.
15. Roehrborn CG, Gregory A, McConnell JD, et al: Comparison of three assays for total serum prostate-specific antigen and percentage of free prostate-specific antigen in predicting prostate histology. Urology 48(suppl): 23-32, 1996.
16. Partin AW, Catalona WJ, Southwick PC, et al: Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: influence of total PSA, prostate volume, and age. Urology 48(suppl): 55-61, 1996.